These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39181498)

  • 1. Soluble fms-like tyrosine kinase-1/placental growth factor ratio at 36 weeks' gestation: association with spontaneous onset of labor and intrapartum fetal compromise in low-risk pregnancies.
    Farina A; Cavoretto PI; Syngelaki A; Adjahou S; Nicolaides KH
    Am J Obstet Gynecol; 2024 Aug; ():. PubMed ID: 39181498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ratio of soluble fms-like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with suspected preeclampsia: a secondary analysis of the INSPIRE trial.
    Palma Dos Reis CR; O'Sullivan J; Ohuma EO; James T; Papageorghiou AT; Vatish M; Cerdeira AS
    Am J Obstet Gynecol; 2024 Jun; ():. PubMed ID: 38897339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum levels of soluble fms-like tyrosine kinase-1 and placental growth factor at 20 and 28 weeks of gestational age and the risk of spontaneous preterm birth.
    Sovio U; Gaccioli F; Cook E; Charnock-Jones DS; Smith GCS
    Am J Obstet Gynecol; 2023 Aug; 229(2):164.e1-164.e18. PubMed ID: 36758709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predelivery placenta-associated biomarkers and computerized intrapartum fetal heart rate patterns.
    Bowe S; Mitlid-Mork B; Gran JM; Distante S; Redman CWG; Staff AC; Georgieva A; Sugulle M
    AJOG Glob Rep; 2023 Feb; 3(1):100149. PubMed ID: 36647548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The implications of the Fetal Medicine Foundation 35- to 36-week preeclampsia prediction competing-risk model on timing of birth.
    von Dadelszen P; Syngelaki A; Wright A; Akolekar R; Magee LA; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2023 Apr; 228(4):457.e1-457.e7. PubMed ID: 36206987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slowing of fetal growth and elevated maternal serum sFLT1:PlGF are associated with early term spontaneous labor.
    Sovio U; Gaccioli F; Cook E; Charnock-Jones DS; Smith GCS
    Am J Obstet Gynecol; 2021 Nov; 225(5):520.e1-520.e10. PubMed ID: 33901486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of imminent preeclampsia at 35-37 weeks gestation.
    Ciobanu A; Wright A; Panaitescu A; Syngelaki A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2019 Jun; 220(6):584.e1-584.e11. PubMed ID: 30738886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testing.
    Espinoza J; Calsavara VF; Kilpatrick S; Rana S; Costantine MM; Boggess K; Wylie BJ; Moore Simas TA; Louis JM; Gaw SL; Murtha A; Wiegand S; Gollin Y; Singh D; Silver RM; Durie DE; Panda B; Norwitz ER; Burd I; Plunkett B; Scott RK; Lemoine E; Thadhani R; Karumanchi SA
    Am J Obstet Gynecol; 2024 Sep; 231(3):363.e1-363.e11. PubMed ID: 38825028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis.
    Chaemsaithong P; Gil MM; Chaiyasit N; Cuenca-Gomez D; Plasencia W; Rolle V; Poon LC
    Am J Obstet Gynecol; 2023 Sep; 229(3):222-247. PubMed ID: 36990308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal vascular indices at 36 weeks' gestation in the prediction of preeclampsia.
    Mansukhani T; Wright A; Arechvo A; Lamanna B; Menezes M; Nicolaides KH; Charakida M
    Am J Obstet Gynecol; 2024 Apr; 230(4):448.e1-448.e15. PubMed ID: 37778678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal vascular-placental axis in the third trimester in women with gestational diabetes mellitus, hypertensive disorders, and unaffected pregnancies.
    Chatzakis C; Papavasiliou D; Mansukhani T; Nicolaides KH; Charakida M
    Am J Obstet Gynecol; 2024 Aug; ():. PubMed ID: 39218286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The additive role of angiogenic markers for women with confirmed preeclampsia.
    Suresh S; Patel E; Mueller A; Morgan J; Lewandowski WL; Verlohren S; von Dadelszen P; Magee LA; Rana S
    Am J Obstet Gynecol; 2023 May; 228(5):573.e1-573.e11. PubMed ID: 36356699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world evidence for the utility of serum soluble fms-like tyrosine kinase 1/placental growth factor test for routine clinical evaluation of hospitalized women with hypertensive disorders of pregnancy.
    Burns LP; Potchileev S; Mueller A; Azzi M; Premkumar A; Peterson J; Rausch A; Gonzalez M; Silasi M; Karumanchi SA; Thadhani R; Rana S
    Am J Obstet Gynecol; 2024 Jul; ():. PubMed ID: 39029547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
    Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
    Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High early pregnancy body mass index is associated with alterations in first- and second-trimester angiogenic biomarkers.
    Beck C; Allshouse A; Silver RM; Grobman WA; Simhan H; Haas D; Reddy UM; Blue NR
    Am J Obstet Gynecol MFM; 2022 May; 4(3):100614. PubMed ID: 35283347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal screening for preeclampsia: the roles of placental growth factor and pregnancy-associated plasma protein A in the first trimester and placental growth factor and soluble fms-like tyrosine kinase 1-placental growth factor ratio in the early second trimester.
    Huang T; Rashid S; Priston M; Rasasakaram E; Mak-Tam E; Gibbons C; Mei-Dan E; Bedford HM
    AJOG Glob Rep; 2023 May; 3(2):100193. PubMed ID: 37168546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the angiogenic biomarker profile to risk stratify patients with fetal growth restriction.
    Arenas GA; Tang NY; Mueller A; Lopes Perdigao J; Kaur H; Abramowicz JS; Mussatt K; Yeo KJ; Rana S
    Am J Obstet Gynecol MFM; 2021 Jul; 3(4):100394. PubMed ID: 33991706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.
    Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
    Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal serum soluble fms-like tyrosine kinase-1-to-placental growth factor ratio distinguishes growth-restricted from non-growth-restricted small-for-gestational-age fetuses.
    Rajiv P; Cade T; Dean J; Jones GD; Brennecke SP
    AJOG Glob Rep; 2024 Feb; 4(1):100302. PubMed ID: 38318268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian population.
    Kumar N; Das V; Agarwal A; Agrawal S
    AJOG Glob Rep; 2023 May; 3(2):100177. PubMed ID: 36911235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.